Next Post

UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors

[ad_1] Unity Biotechnology, Inc. SAN FRANCISCO, May 26, 2022 (World NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology corporation acquiring therapeutics to sluggish, halt, or reverse conditions of getting old, these days introduced that Michael Samar, recent chief monetary officer at Assembly Bio, has been appointed to the […]

Subscribe US Now